Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanism of Action of Cavinton (vinpocetine) on Endothelium and Peripheral Circulation
2006-004641-42Phase 4Completed
- Sponsor
- Gedeon Richter Plc
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of vinpocetine in Large Artery Atherosclerotic Stroke, endothelial dysfunction and peripheral vascular disease (PVD), sponsored by Gedeon Richter Plc. Primary endpoint: Change from baseline in vascular and endothelial function parameters. Started Dec 2006; status: completed.
02
Drugs
vinpocetine
03
Conditions
Large Artery Atherosclerotic Strokeendothelial dysfunctionperipheral vascular disease (PVD)
Beyond the preview
Go deeper on 2006-004641-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004641-42.